ProShare Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Sell |
|
|||||
|
2025
Q1 | $406K | Sell |
|
|||||
|
2024
Q4 | $471K | Buy |
|
|||||
|
2024
Q3 | $250K | Buy |
|
|||||
|
2024
Q2 | $104K | Sell |
|
|||||
|
2024
Q1 | $133K | Buy |
|
|||||
|
2023
Q4 | $122K | Buy |
|
|||||
|
2023
Q3 | $66.8K | Sell |
|
|||||
|
2023
Q2 | $49.1K | Buy |
|
|||||
|
2023
Q1 | $16.8K | Sell |
|
|||||
|
2022
Q4 | $26.4K | Buy |
|
|||||
|
2022
Q3 | $23K | Sell |
|
|||||
|
2022
Q2 | $37K | Sell |
|
|||||
|
2022
Q1 | $78K | Sell |
|
|||||
|
2021
Q4 | $105K | Buy |
|
|||||
|
2021
Q3 | $68K | Sell |
|
|||||
|
2021
Q2 | $132K | Sell |
|
|||||
|
2021
Q1 | $179K | Buy |
|
|||||
|
2020
Q4 | $100K | Buy |
|
|||||
|
2020
Q3 | $47K | Sell |
|
|||||
|
2020
Q2 | $64K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $77K | Buy |
|
|||||
|
2019
Q3 | $31K | Sell |
|
|||||
|
2019
Q2 | $80K | Sell |
|
|||||
|
2019
Q1 | $179K | Buy |
|
|||||
|
2018
Q4 | $155K | Sell |
|
|||||
|
2018
Q3 | $294K | Buy |
|
|||||
|
2018
Q2 | $217K | Buy |
|